Orally administered Lactiplantibacillus plantarum OLL2712 decreased intestinal permeability, especially in the ileum: Ingested lactic acid bacteria alleviated obesity-induced inflammation by collaborating with gut microbiota

IntroductionChronic inflammation caused by dietary obesity has been considered to induce lifestyle-related diseases and functional ingredients with anti-inflammatory effects are attracting attention. Although multiple studies on obesity had proved the anti-inflammatory effects of ingestion of lactic...

Full description

Bibliographic Details
Main Authors: Yimei Wang, Tomohiro Takano, Yingyu Zhou, Rong Wang, Takayuki Toshimitsu, Toshihiro Sashihara, Masaru Tanokura, Takuya Miyakawa, Haruyo Nakajima-Adachi, Satoshi Hachimura
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1123052/full
_version_ 1797897228664176640
author Yimei Wang
Tomohiro Takano
Yingyu Zhou
Rong Wang
Takayuki Toshimitsu
Toshihiro Sashihara
Masaru Tanokura
Masaru Tanokura
Takuya Miyakawa
Takuya Miyakawa
Haruyo Nakajima-Adachi
Satoshi Hachimura
author_facet Yimei Wang
Tomohiro Takano
Yingyu Zhou
Rong Wang
Takayuki Toshimitsu
Toshihiro Sashihara
Masaru Tanokura
Masaru Tanokura
Takuya Miyakawa
Takuya Miyakawa
Haruyo Nakajima-Adachi
Satoshi Hachimura
author_sort Yimei Wang
collection DOAJ
description IntroductionChronic inflammation caused by dietary obesity has been considered to induce lifestyle-related diseases and functional ingredients with anti-inflammatory effects are attracting attention. Although multiple studies on obesity had proved the anti-inflammatory effects of ingestion of lactic acid bacteria (LAB) and other functional ingredients on adipose tissue, the precise effects on the intestine, especially on the individual intestinal segments have not been made clear. In this study, we elucidated the mechanisms of Lactiplantibacillus plantarum (basonym: Lactobacillus plantarum) OLL2712 in suppressing obesity-induced inflammation using high fat diet (HFD)-fed mice obesity model.MethodsWe orally administered heat-treated LAB to HFD-fed mice model, and investigated the inflammatory changes in adipose tissue and intestinal immune cells. We also analyzed gut microbiota, and evaluated the inflammation and permeability of the duodenum, jejunum, ileum and colon; four intestinal segments differing in gut bacteria composition and immune response.ResultsAfter 3-week LAB administration, the gene expression levels of proinflammatory cytokines were downregulated in adipose tissue, colon, and Peyer’s patches (PP)-derived F4/80+ cells. The LAB treatment alleviated obesity-related gut microbiota imbalance. L. plantarum OLL2712 treatment helps maintain intestinal barrier function, especially in the ileum, possibly by preventing ZO-1 and Occludin downregulation.DiscussionOur results suggest that the oral administration of the LAB strain regulated the gut microbiota, suppressed intestinal inflammation, and improved the gut barrier, which could inhibit the products of obesity-induced gut dysbiosis from translocating into the bloodstream and the adipose tissue, through which the LAB finally alleviated the inflammation caused by dietary obesity. Barrier improvement was observed, especially in the ileum, suggesting collaborative modulation of the intestinal immune responses by ingested LAB and microbiota.
first_indexed 2024-04-10T07:55:20Z
format Article
id doaj.art-65684b9e306f4dd6b1a30cdd5d086023
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T07:55:20Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-65684b9e306f4dd6b1a30cdd5d0860232023-02-23T04:50:10ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-02-011410.3389/fimmu.2023.11230521123052Orally administered Lactiplantibacillus plantarum OLL2712 decreased intestinal permeability, especially in the ileum: Ingested lactic acid bacteria alleviated obesity-induced inflammation by collaborating with gut microbiotaYimei Wang0Tomohiro Takano1Yingyu Zhou2Rong Wang3Takayuki Toshimitsu4Toshihiro Sashihara5Masaru Tanokura6Masaru Tanokura7Takuya Miyakawa8Takuya Miyakawa9Haruyo Nakajima-Adachi10Satoshi Hachimura11Research Center for Food Safety, The University of Tokyo, Tokyo, JapanResearch Center for Food Safety, The University of Tokyo, Tokyo, JapanDepartment of Applied Biological Chemistry, The University of Tokyo, Tokyo, JapanDepartment of Applied Biological Chemistry, The University of Tokyo, Tokyo, JapanCo-Creation Center, Meiji Holdings Co., Ltd, Hachiouji, JapanCo-Creation Center, Meiji Holdings Co., Ltd, Hachiouji, JapanResearch Center for Food Safety, The University of Tokyo, Tokyo, JapanDepartment of Applied Biological Chemistry, The University of Tokyo, Tokyo, JapanDepartment of Applied Biological Chemistry, The University of Tokyo, Tokyo, JapanGraduate School of Biostudies, Kyoto University, Kyoto, JapanResearch Center for Food Safety, The University of Tokyo, Tokyo, JapanResearch Center for Food Safety, The University of Tokyo, Tokyo, JapanIntroductionChronic inflammation caused by dietary obesity has been considered to induce lifestyle-related diseases and functional ingredients with anti-inflammatory effects are attracting attention. Although multiple studies on obesity had proved the anti-inflammatory effects of ingestion of lactic acid bacteria (LAB) and other functional ingredients on adipose tissue, the precise effects on the intestine, especially on the individual intestinal segments have not been made clear. In this study, we elucidated the mechanisms of Lactiplantibacillus plantarum (basonym: Lactobacillus plantarum) OLL2712 in suppressing obesity-induced inflammation using high fat diet (HFD)-fed mice obesity model.MethodsWe orally administered heat-treated LAB to HFD-fed mice model, and investigated the inflammatory changes in adipose tissue and intestinal immune cells. We also analyzed gut microbiota, and evaluated the inflammation and permeability of the duodenum, jejunum, ileum and colon; four intestinal segments differing in gut bacteria composition and immune response.ResultsAfter 3-week LAB administration, the gene expression levels of proinflammatory cytokines were downregulated in adipose tissue, colon, and Peyer’s patches (PP)-derived F4/80+ cells. The LAB treatment alleviated obesity-related gut microbiota imbalance. L. plantarum OLL2712 treatment helps maintain intestinal barrier function, especially in the ileum, possibly by preventing ZO-1 and Occludin downregulation.DiscussionOur results suggest that the oral administration of the LAB strain regulated the gut microbiota, suppressed intestinal inflammation, and improved the gut barrier, which could inhibit the products of obesity-induced gut dysbiosis from translocating into the bloodstream and the adipose tissue, through which the LAB finally alleviated the inflammation caused by dietary obesity. Barrier improvement was observed, especially in the ileum, suggesting collaborative modulation of the intestinal immune responses by ingested LAB and microbiota.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1123052/fullobesityproinflammatory cytokinesmacrophagesgut microbiotaintestinal permeabilitylactic acid bacteria
spellingShingle Yimei Wang
Tomohiro Takano
Yingyu Zhou
Rong Wang
Takayuki Toshimitsu
Toshihiro Sashihara
Masaru Tanokura
Masaru Tanokura
Takuya Miyakawa
Takuya Miyakawa
Haruyo Nakajima-Adachi
Satoshi Hachimura
Orally administered Lactiplantibacillus plantarum OLL2712 decreased intestinal permeability, especially in the ileum: Ingested lactic acid bacteria alleviated obesity-induced inflammation by collaborating with gut microbiota
Frontiers in Immunology
obesity
proinflammatory cytokines
macrophages
gut microbiota
intestinal permeability
lactic acid bacteria
title Orally administered Lactiplantibacillus plantarum OLL2712 decreased intestinal permeability, especially in the ileum: Ingested lactic acid bacteria alleviated obesity-induced inflammation by collaborating with gut microbiota
title_full Orally administered Lactiplantibacillus plantarum OLL2712 decreased intestinal permeability, especially in the ileum: Ingested lactic acid bacteria alleviated obesity-induced inflammation by collaborating with gut microbiota
title_fullStr Orally administered Lactiplantibacillus plantarum OLL2712 decreased intestinal permeability, especially in the ileum: Ingested lactic acid bacteria alleviated obesity-induced inflammation by collaborating with gut microbiota
title_full_unstemmed Orally administered Lactiplantibacillus plantarum OLL2712 decreased intestinal permeability, especially in the ileum: Ingested lactic acid bacteria alleviated obesity-induced inflammation by collaborating with gut microbiota
title_short Orally administered Lactiplantibacillus plantarum OLL2712 decreased intestinal permeability, especially in the ileum: Ingested lactic acid bacteria alleviated obesity-induced inflammation by collaborating with gut microbiota
title_sort orally administered lactiplantibacillus plantarum oll2712 decreased intestinal permeability especially in the ileum ingested lactic acid bacteria alleviated obesity induced inflammation by collaborating with gut microbiota
topic obesity
proinflammatory cytokines
macrophages
gut microbiota
intestinal permeability
lactic acid bacteria
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1123052/full
work_keys_str_mv AT yimeiwang orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT tomohirotakano orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT yingyuzhou orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT rongwang orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT takayukitoshimitsu orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT toshihirosashihara orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT masarutanokura orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT masarutanokura orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT takuyamiyakawa orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT takuyamiyakawa orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT haruyonakajimaadachi orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota
AT satoshihachimura orallyadministeredlactiplantibacillusplantarumoll2712decreasedintestinalpermeabilityespeciallyintheileumingestedlacticacidbacteriaalleviatedobesityinducedinflammationbycollaboratingwithgutmicrobiota